Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]: Side Effects & Safety Data for 6 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] includes 6 drugs with a combined 61,375 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
6
Drugs in Class
61,375
Combined Reports
All Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| TENOFOVIR DISOPROXIL | Tenofovir Disoproxil Fumarate | 26,978 | 1,235 | 3,617 | 4.6% |
| LAMIVUDINE | Lamivudine and Zidovudine | 16,685 | 1,838 | 3,442 | 11.0% |
| ZIDOVUDINE | RETROVIR | 6,722 | 816 | 1,067 | 12.1% |
| ABACAVIR | Abacavir Sulfate | 4,282 | 524 | 890 | 12.2% |
| EMTRICITABINE | Truvada | 3,718 | 499 | 797 | 13.4% |
| TENOFOVIR ALAFENAMIDE | VEMLIDY | 2,990 | 311 | 713 | 10.4% |
Common Side Effects in Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Bone density decreased | 10,668 | 159 |
| Renal injury | 9,323 | 168 |
| Skeletal injury | 8,320 | 172 |
| Chronic kidney disease | 7,441 | 221 |
| Osteonecrosis | 7,302 | 107 |
| Bone loss | 7,046 | 107 |
| Multiple fractures | 6,818 | 109 |
| Renal failure | 6,796 | 395 |
| Foetal exposure during pregnancy | 5,798 | 792 |
| Osteoporosis | 5,567 | 89 |